🎗️ Oncology Papers

Scholarly works matching "oncology" in Crossref, sorted by the number of times other DOI-registered works cite them. Citation counts come from Crossref and are usually lower than Google Scholar figures.

575 top-cited papers indexed

Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology

David S. Ettinger, Douglas E. Wood et al. (2022)

Journal of the National Comprehensive Cancer Network

1.2K citesjournal articlePDF

Use of Positron Emission Tomography for Response Assessment of Lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma

Malik E. Juweid, Sigrid Stroobants et al. (2007)

Journal of Clinical Oncology

1.1K citesjournal articlePDF

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

Maura L Gillison, Andy M Trotti et al. (2019)

The Lancet

1.2K citesjournal articlePDF

OCEANS: A Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Chemotherapy With or Without Bevacizumab in Patients With Platinum-Sensitive Recurrent Epithelial Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Carol Aghajanian, Stephanie V. Blank et al. (2012)

Journal of Clinical Oncology

1.2K citesjournal articlePDF

Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial

Thierry Conroy, Jean-François Bosset et al. (2021)

The Lancet Oncology

1.3K citesjournal articlePDF

Immune checkpoint inhibitors for patients with advanced lung cancer and oncogenic driver alterations: results from the IMMUNOTARGET registry

J. Mazieres, A. Drilon et al. (2019)

Annals of Oncology

1.2K citesjournal articlePDF

The carcinogenicity of outdoor air pollution

Dana Loomis, Yann Grosse et al. (2013)

The Lancet Oncology

1.2K citesjournal articlePDF

Prostate cancer radiation dose response: results of the M. D. Anderson phase III randomized trial

Alan Pollack, Gunar K Zagars et al. (2002)

International Journal of Radiation Oncology*Biology*Physics

1.1K citesjournal articlePDF

Patient-derived tumour xenografts as models for oncology drug development

John J. Tentler, Aik Choon Tan et al. (2012)

Nature Reviews Clinical Oncology

1.2K citesjournal articlePDF

Comparison of an Oral Factor Xa Inhibitor With Low Molecular Weight Heparin in Patients With Cancer With Venous Thromboembolism: Results of a Randomized Trial (SELECT-D)

Annie M. Young, Andrea Marshall et al. (2018)

Journal of Clinical Oncology

1.2K citesjournal articlePDF

Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens

Mark E. Dudley, James C. Yang et al. (2008)

Journal of Clinical Oncology

1.2K citesjournal articlePDF

Safety and activity of blinatumomab for adult patients with relapsed or refractory B-precursor acute lymphoblastic leukaemia: a multicentre, single-arm, phase 2 study

Max S Topp, Nicola Gökbuget et al. (2015)

The Lancet Oncology

1.2K citesjournal articlePDF

Laparoscopy Compared With Laparotomy for Comprehensive Surgical Staging of Uterine Cancer: Gynecologic Oncology Group Study LAP2

Joan L. Walker, Marion R. Piedmonte et al. (2009)

Journal of Clinical Oncology

1.1K citesjournal articlePDF

Targeting Notch, Hedgehog, and Wnt pathways in cancer stem cells: clinical update

Naoko Takebe, Lucio Miele et al. (2015)

Nature Reviews Clinical Oncology

1.2K citesjournal articlePDF

Stereotactic Ablative Radiotherapy for the Comprehensive Treatment of Oligometastatic Cancers: Long-Term Results of the SABR-COMET Phase II Randomized Trial

David A. Palma, Robert Olson et al. (2020)

Journal of Clinical Oncology

1.2K citesjournal articlePDF